428 related articles for article (PubMed ID: 22622903)
1. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
2. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
3. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
4. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
Kuo HC
Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Lee CL; Kuo HC
Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
[TBL] [Abstract][Full Text] [Related]
7. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Kuo YC; Kuo HC
Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
Jiang YH; Jhang JF; Lee CL; Kuo HC
Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
11. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
12. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
Peng CH; Jhang JF; Shie JH; Kuo HC
Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
[TBL] [Abstract][Full Text] [Related]
14. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
15. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome.
Lee WC; Chuang YC; Lee WC; Chiang PH
Kaohsiung J Med Sci; 2011 Oct; 27(10):437-40. PubMed ID: 21943815
[TBL] [Abstract][Full Text] [Related]
16. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
17. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Wang HJ; Yu WR; Ong HL; Kuo HC
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
[TBL] [Abstract][Full Text] [Related]
18. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome.
Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG
BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619
[TBL] [Abstract][Full Text] [Related]
19. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
20. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
Lai MC; Kuo YC; Kuo HC
Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
